VPTDF (VentriPoint Diagnostics) Cyclically Adjusted PB Ratio: (As of Jul. 09, 2026)


What is VentriPoint Diagnostics Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


VentriPoint Diagnostics  (OTCPK:VPTDF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


VentriPoint Diagnostics Cyclically Adjusted PB Ratio Related Terms


VentriPoint Diagnostics Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for VentriPoint Diagnostics's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

VentriPoint Diagnostics Cyclically Adjusted PB Ratio Chart

VentriPoint Diagnostics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

VentriPoint Diagnostics Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

VPTDF vs ABT, SYK, MDT: Cyclically Adjusted PB Ratio Comparison

For the Medical Devices subindustry, VentriPoint Diagnostics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


VentriPoint Diagnostics Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, VentriPoint Diagnostics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where VentriPoint Diagnostics's Cyclically Adjusted PB Ratio falls into.



VentriPoint Diagnostics Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

VentriPoint Diagnostics's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2025 is calculated as:

For example, VentriPoint Diagnostics's adjusted Book Value per Share data for the three months ended in Dec. 2025 was:

Adj_Book=Book Value per Share/CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=-0.018/130.3661*130.3661
=-0.018

Current CPI (Dec. 2025) = 130.3661.

VentriPoint Diagnostics Quarterly Data

Book Value per Share CPI Adj_Book
201603 -0.019 101.054 -0.025
201606 -0.040 102.002 -0.051
201609 -0.054 101.765 -0.069
201612 -0.052 101.449 -0.067
201703 -0.052 102.634 -0.066
201706 -0.012 103.029 -0.015
201709 -0.003 103.345 -0.004
201712 -0.025 103.345 -0.032
201803 -0.017 105.004 -0.021
201806 -0.017 105.557 -0.021
201809 -0.002 105.636 -0.002
201812 -0.012 105.399 -0.015
201903 -0.019 106.979 -0.023
201906 -0.027 107.690 -0.033
201909 -0.030 107.611 -0.036
201912 -0.027 107.769 -0.033
202003 -0.028 107.927 -0.034
202006 -0.032 108.401 -0.038
202009 -0.025 108.164 -0.030
202012 -0.020 108.559 -0.024
202103 0.004 110.298 0.005
202106 0.013 111.720 0.015
202109 0.010 112.905 0.012
202112 0.042 113.774 0.048
202203 0.038 117.646 0.042
202206 0.032 120.806 0.035
202209 0.026 120.648 0.028
202212 0.021 120.964 0.023
202303 0.016 122.702 0.017
202306 0.011 124.203 0.012
202309 0.006 125.230 0.006
202312 0.001 125.072 0.001
202403 -0.004 126.258 -0.004
202406 -0.010 127.522 -0.010
202409 -0.011 127.285 -0.011
202412 -0.013 127.364 -0.013
202503 -0.015 129.181 -0.015
202506 -0.018 129.892 -0.018
202509 -0.020 130.287 -0.020
202512 -0.018 130.366 -0.018

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


VentriPoint Diagnostics Business Description

Other Exchanges VPT:Canada
Address 18 Hook Avenue, Unit 101, Toronto, ON, CAN, M6P 1T4
VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. Its flagship product, the Ventripoint Medical System (VMS+), transforms standard 2D and 3D echocardiography and MRI images into accurate three-dimensional heart models and volumetric measurements, enabling clinicians to assess disease severity, track progression, evaluate treatment response, and guide surgical and pharmacological decisions. Additionally, the company has developed VMS+ 3D Echo and MRI software that can be installed on any personal workstation to create a 3D model of the heart's chamber. Geographically, its products are sold in Canada and internationally.